ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,854Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 434

$402K Total Retail Price of All Prescriptions

Rank: 69 out of 434

603 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,106 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 489 433 1 2
LEVOTHYROXINE SODIUM 459 412 2 3
HYDROCODONE-ACETAMINOPHEN 367 322 S3 3 4
OMEPRAZOLE 347 307 4 5
LISINOPRIL 297 270 5 1
AMLODIPINE BESYLATE 235 193 6 6
METOPROLOL SUCCINATE 233 227 7 22
ZOLPIDEM TARTRATE 213 205 8 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 209 192 9 21
ATORVASTATIN CALCIUM 204 193 10 19
METFORMIN HCL 191 181 11 7
MELOXICAM 156 149 12 46
WARFARIN SODIUM 152 144 13 18
HYDROCHLOROTHIAZIDE 147 137 14 8
ATENOLOL 133 113 15 16
METOPROLOL TARTRATE 120 117 16 12
PAROXETINE HCL 112 100 17 61
LOVASTATIN 104 103 18 10
POTASSIUM CHLORIDE 99 99 19 20
ALENDRONATE SODIUM 99 94 19 15
GABAPENTIN 92 84 21 14
PRAVASTATIN SODIUM 90 86 22 17
LOSARTAN POTASSIUM 86 84 23 13
FLUTICASONE PROPIONATE 77 77 24 26
CLOPIDOGREL 68 66 25 41
BACLOFEN 66 26 26 77
ALLOPURINOL 66 63 26 25
LOSARTAN-HYDROCHLOROTHIAZIDE 61 58 28 39
GLYBURIDE 60 60 R 29 51
PLAVIX 58 56 30 64
SPIRIVA 58 58 30 36
FUROSEMIDE 56 51 32 9
ADVAIR DISKUS 55 54 33 52
VENTOLIN HFA 50 49 34 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.